Results

Total Results: 272 records

Showing results for "end stage renal".

  1. effectivehealthcare-admin.ahrq.gov/products/nephropathy-contrast-induced/research-protocol
    December 01, 2019 - stage renal disease (ESRD), mortality, and other adverse events? … function measures Development of CKD, including end stage renal disease (ESRD) Rate of conversion … AKI=acute kidney injury; CIN=contrast induces nephropathy; CKD=chronic kidney disease; ESRD=end stagerenal disease; KQ=Key question; RRT=renal replacement therapy Figure 1b. … AKI=acute kidney injury; CIN=contrast induces nephropathy; CKD=chronic kidney disease; ESRD=end stage
  2. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/nephropathy-contrast-induced_research-protocol.pdf
    October 01, 2013 - stage renal disease (ESRD), mortality, and other adverse events? … function measures ● Development of CKD, including end stage renal disease (ESRD) ● Rate of conversion … AKI=acute kidney injury; CIN=contrast induces nephropathy; CKD=chronic kidney disease; ESRD=end stage … AKI=acute kidney injury; CIN=contrast induces nephropathy; CKD=chronic kidney disease; ESRD=end stage … Because of their role as end-users, individuals are invited to serve as Key Informants and those who
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/renal-function_disposition-comments.pdf
    August 11, 2014 - discuss Food and Drug Administration (FDA) approval for troponin T for prognosis in patients with end-stage … Yes, the introduction is a bit long but hopefully sets the stage for how complex troponin interpretation … Table G was results for non-dialysis CKD patients (generally CKD stages 1-4, or stage 5 not on dialysis … We added the following statements to the end of the Data Analysis and Synthesis section of the main … didn’t make sense, the first in the last paragraph of the conclusion on page 119 (similarly at the end
  4. effectivehealthcare-admin.ahrq.gov/products/cer-methods-4th-symposium/overview
    November 01, 2018 - analyses estimate different parameters of the effect of erythropoietin stimulating agents on survival in endstage renal disease: a comparison of payment policy analysis, instrumental variables, and multiple imputation … analyses estimate different parameters of the effect of erythropoietin stimulating agents on survival in endstage renal disease: a comparison of payment policy analysis, instrumental variables, and multiple imputation
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-update_research-protocol.pdf
    May 07, 2010 - The system can be triggered by sympathetic stimulation, renal artery hypotension, and decreased sodium … used extensively for treatment of hypertension, heart failure, myocardial infarction, diabetes, and renal … events [MI], heart failure, cerebral vascular disease or events, symptomatic coronary artery disease, end-stage … failure, cerebral vascular disease or events [including stroke], symptomatic coronary artery disease, end-stage … current search strategy and initial number of abstracts to be included in our abstract screening stage
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/heart-failure-rehospitalization_research.pdf
    November 01, 2007 - having an outpatient diagnosis for dyslipidemia and/or receipt of a lipid-lowering medication.(27) End-stage … - stage renal disease/chronic renal failure, chronic lung disease, known atrial fibrillation or flutter … angina or coronary artery disease, prior stroke or transient ischemic attack, diagnosed hypertension, end-stage … no β-blocker) Dyslipidemia 4,754(41.7) 3,791(47.2) 963(28.6) <0.001 End-stage renal disease or chronic … Identified from Kaiser End-Stage Renal Disease Treatment Registry which includes patients receiving
  7. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/bladder-cancer-muscle-invasive_executive.pdf
    June 01, 2015 - stage cancers invade beyond the muscle layer into surrounding fat (stage classification T3 bladder … For example, medically frail patients with baseline renal insufficiency may not be ideal candidates … for cisplatin-based therapy because of potential renal toxicity. … Surveillance Epidemiology and End Results. … patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End
  8. effectivehealthcare-admin.ahrq.gov/products/kidney-disease-medicine/research
    December 01, 2019 - angiotensin receptor blockers (ARBs) (RR 0.77, 95 percent CI, 0.66 to 0.90) significantly reduced risk of end-stagerenal disease (ESRD) versus placebo.
  9. effectivehealthcare-admin.ahrq.gov/products/diabetes-update-2015/research-protocol
    December 01, 2019 - cardiovascular-related death nearly two-fold and is the leading cause of new-onset blindness and new-onset end-stage … include studies where everyone included has at least one of the following comorbid conditions: End-stage … liver disease or cirrhosis End-stage renal disease (i.e., stage 5 chronic kidney disease or dialysis … Inclusion and exclusion criteria PICOTS Inclusion criteria Exclusion criteria ESLD = end-stage … liver disease; ESRD = end-stage renal disease; KQ = Key Question; RCT = randomized controlled trial
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
    January 01, 2007 - stage renal disease, peripheral vascular disease, and quality of life). … failure, cerebral vascular disease or events [including stroke], symptomatic coronary artery disease, end-stage … Abbreviations: CAD = coronary artery disease; ESRD = end-stage renal disease; HTN = hypertension; LVEF … One of these studies was conducted in patients with end-stage renal disease who had been on maintenance … DBP Diastolic blood pressure EF Ejection fraction EPC Evidence-based Practice Centers ESRD End-stage
  11. effectivehealthcare-admin.ahrq.gov/health-topics/dietary-proteins?page=3
    August 29, 2011 - Protocol Archived August 29, 2011 Laboratory Biomarkers for Iron Deficiency Anemia in Late Stage … Comparative Effectiveness Research to Improve Anemia Management and Cardiovascular Disease Outcomes in End-StageRenal Disease (ESRD) Systematic Review Archived March 15, 2011 Oral Diabetes Medications
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/fetal-surgery_disposition-comments.pdf
    July 05, 2011 - injury (end-stage dysplasia). … statement that “[Greater than 90percent] of pregnancies…presenting with TTTS prior to26 weeks will end … qualified: most pregnancies(but probably not greater than 90%) with severe ANDworsening TTTS will endStage I twin-twin transfusionsyndrome: rates of progression and regression in relationto outcome. … percent of pregnancies presenting with severe TTTS and not undergoing some sort of therapy will end
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/diabetes-update-2015_research-protocol.pdf
    January 01, 2015 - cardiovascular-related death nearly two-fold and is the leading cause of new-onset blindness and new-onset end-stage … include studies where everyone included has at least one of the following comorbid conditions: • End-stage … liver disease or cirrhosis • End-stage renal disease (i.e., stage 5 chronic kidney disease or dialysis … ESLD = end-stage liver disease; ESRD = end-stage renal disease; KQ = Key Question; RCT = randomized controlled … If data are not presented at the end of the first period, then we will exclude the article for the
  14. effectivehealthcare-admin.ahrq.gov/products/gout/research-protocol
    March 01, 2020 - Therefore primary care physicians (PCPs) and emergency physicians are well-positioned to diagnose early-stage … The search strategy appears at the end of this protocol. … Full-text articles will be dually reviewed; disagreements regarding inclusion at the full-text stage … At the end of the project, abstracted data will be uploaded to the Systematic Review Data Repository. … comorbidities, we will determine whether studies report factors such as sex, duration of the condition, and stage
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/gout_research-protocol.pdf
    November 03, 2014 - Therefore primary care physicians (PCPs) and emergency physicians are well-positioned to diagnose early-stage … The search strategy appears at the end of this protocol. … Full-text articles will be dually reviewed; disagreements regarding inclusion at the full-text stage … At the end of the project, abstracted data will be uploaded to the Systematic Review Data Repository … Because of their role as end-users, individuals are invited to serve as Key Informants and those who
  16. effectivehealthcare-admin.ahrq.gov/products/disparities-quality-improvement/research-protocol
    December 01, 2019 - Major depressive disorder Asthma Cystic fibrosis Pneumonia, including pneumococcal vaccination End-stage … acute coronary syndrome]; asthma, major depressive disorder asthma, cystic fibrosis, pneumonia, and end-stagerenal disease). … Major depressive disorder Asthma Cystic fibrosis Pneumonia including pneumococcal vaccination End-stagestage renal disease.
  17. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-2007_executive.pdf
    January 01, 2007 - The primary site of renin release is the kidney, and release is triggered by sympathetic stimulation, renal … used extensively for treatment of hypertension, heart failure, myocardial infarction, diabetes, and renal … failure, cerebral vascular disease or events [including stroke], symptomatic coronary artery disease, endstage renal disease, peripheral vascular disease, and quality of life). 4Safety outcomes considered … disease (either based on creatinine, GFR, or renal disease) proteinuria).
  18. effectivehealthcare-admin.ahrq.gov/products/vte-prophyalaxis/research-protocol
    December 01, 2019 - failure, chronic renal failure, or end-stage renal disease. 26-29 Not only are these special populations … In a prospective community-based cohort, patients with stage 3 or 4 chronic kidney disease (CKD) had … higher risk of VTE than those with normal kidney function. 26 The rates of VTE among patients with end-stagerenal disease were also high. … Because of their role as end-users, individuals are invited to serve as Key Informants and those who
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
    November 01, 2012 - RLS is unknown, but the disorder also occurs secondary to other conditions such as iron deficiency, end-stage … characteristics (age, sex, race, comorbidities, disease severity, etiology, iron status, pregnancy, end-stage … of RLS (time since diagnosis), baseline RLS symptom severity and frequency, iron, pregnancy, and end-stage … • No eligible studies enrolled individuals with end-stage renal disease, and almost all specifically … We identified one other study in adults with RLS believed secondary to end-stage renal disease.
  20. effectivehealthcare-admin.ahrq.gov/health-topics/vascular-diseases?page=2
    March 05, 2012 - 2011 Comparative Effectiveness of Antihypertensive Therapies on Cardiovascular Disease Outcomes In End-StageRenal Disease Research Report March 8, 2011 Data Points #3: Economic burden of diabetic

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: